Dr. Mitesh Kapadia, MD, PhD Launches Eyelid Skin Cancer Awareness Campaign
Eyelid cancer accounts for approximately five to ten percent of skin cancers and 90 percent of patients diagnosed with this type of skin cancer find theirs is of the basal cell carcinoma type. When detected and treated early, patients find this type of cancer is typically curable, yet the significant risk of damage to nearby ocular structures remains of concern. Some patients find the cancer leads to blindness, when the tumor isn't removed in a timely manner. For this reason, individuals need to ensure they seek treatment when a scar-like texture or appearance develops on an eyelid or a tumor begins to develop.
Dr. Mitesh Kapadia Receives Prestigious RealSelf 100 Award
Cosmetic surgeon Mitesh Kapadia, M.D., Ph.D., was named a recipient of the RealSelf 100 award. Beginning from a pool of over 6,000 eligible board-certified specialists, the award jury selected the 100 who demonstrated the highest degree of commitment and expertise at educating and helping patients understand their elective cosmetic surgery options. The award is one of a number of such recognitions Kapadia has received over the course of his career as an oculoplastic surgeon, the pursuit of which includes work at an academic practice at Boston's Tufts Medical Center and a private one in Wellesley.